154 related articles for article (PubMed ID: 26545574)
21. PDE5 inhibitors for erectile dysfunction revisited.
Med Lett Drugs Ther; 2012 Feb; 54(1383):10-1. PubMed ID: 22354220
[No Abstract] [Full Text] [Related]
22. Efficacy and safety of phosphodiesterase-5 inhibitors for treating erectile dysfunction in kidney transplant recipients: a meta-analysis.
Fanbin L; Mei Y; Yan Z; Yirong Y; Shaoling Z; Yong C; Peng X
Exp Clin Transplant; 2014 Jun; 12(3):184-9. PubMed ID: 24907716
[TBL] [Abstract][Full Text] [Related]
23. Leber's hereditary optic neuropathy precipitated by tadalafil use for erectile dysfunction.
Cornish KS; Barras C
Semin Ophthalmol; 2011 Jan; 26(1):7-10. PubMed ID: 21275598
[TBL] [Abstract][Full Text] [Related]
24. Avanafil, a new rapid-onset phosphodiesterase 5 inhibitor for the treatment of erectile dysfunction.
Limin M; Johnsen N; Hellstrom WJ
Expert Opin Investig Drugs; 2010 Nov; 19(11):1427-37. PubMed ID: 20939743
[TBL] [Abstract][Full Text] [Related]
25. Avanafil (Stendra)--another PDE5 inhibitor for erectile dysfunction.
Med Lett Drugs Ther; 2014 May; 56(1442):37-8. PubMed ID: 24818838
[No Abstract] [Full Text] [Related]
26. The safety of phosphodiesterase type 5 inhibitors for erectile dysfunction.
Ventimiglia E; Capogrosso P; Montorsi F; Salonia A
Expert Opin Drug Saf; 2016; 15(2):141-52. PubMed ID: 26752541
[TBL] [Abstract][Full Text] [Related]
27. Re: Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis.
Seftel A
J Urol; 2013 Oct; 190(4):1340. PubMed ID: 24029345
[No Abstract] [Full Text] [Related]
28. Insurance coverage for erectile dysfunction drugs.
Hornbrook MC; Holup J
Clin Pharmacol Ther; 2011 Jan; 89(1):19-21. PubMed ID: 21170065
[No Abstract] [Full Text] [Related]
29. Cases of Ischemic Optic Neuropathy Associated With Phosphodiesterase-5 Inhibitor Use Reported to the Food and Drug Administration Adverse Event Reporting System.
Pomeranz HD
J Neuroophthalmol; 2016 Jun; 36(2):221-2. PubMed ID: 26963573
[No Abstract] [Full Text] [Related]
30. [Side effects of erectile dysfunction drug treatment].
Sperling H
Urologe A; 2017 Apr; 56(4):451-455. PubMed ID: 28251255
[TBL] [Abstract][Full Text] [Related]
31. [Efficacy and tolerance of PDE-5 in the treatment of erectile dysfunction in schizophrenic patients: A literature review].
Bacconi L; Gressier F
Encephale; 2017 Feb; 43(1):55-61. PubMed ID: 27658991
[TBL] [Abstract][Full Text] [Related]
32. Are phosphodiesterase type 5 inhibitors associated with increased risk of melanoma?: A systematic review and meta-analysis.
Feng S; Zhou L; Liu Q; He Q; Liao B; Wei X; Li H; Wang K; Zhu Y
Medicine (Baltimore); 2018 Jan; 97(3):e9601. PubMed ID: 29504984
[TBL] [Abstract][Full Text] [Related]
33. Erectile disfunction medical treatment with phosphodiesterase 5 inhibitors (PDE5i) in patients with retinitis pigmentosa and side effects.
Cocci A; Romano A; Morelli G; Frediani D; Sodi A; Russo GI
Arch Ital Urol Androl; 2020 Dec; 92(4):. PubMed ID: 33348949
[TBL] [Abstract][Full Text] [Related]
34. Phosphodiesterase type 5 (PDE5) inhibitors for the treatment of erectile dysfunction.
Dorsey P; Keel C; Klavens M; Hellstrom WJ
Expert Opin Pharmacother; 2010 May; 11(7):1109-22. PubMed ID: 20402554
[TBL] [Abstract][Full Text] [Related]
35. [ Editorial. Pharmazie in unserer Zeit 5/2010].
Dingermann T; Schubert-Zsilavecz M
Pharm Unserer Zeit; 2010 Sep; 39(5):331. PubMed ID: 20818677
[No Abstract] [Full Text] [Related]
36. Diagnosis and treatment of erectile dysfunction for reduction of cardiovascular risk.
Nehra A; Jackson G; Miner M; Billups KL; Burnett AL; Buvat J; Carson CC; Cunningham GR; Goldstein I; Guay AT; Hackett G; Kloner RA; Kostis J; Montorsi P; Ramsey M; Rosen RC; Sadovsky R; Seftel AD; Vlachopoulos C; Wu FC
J Urol; 2013 Jun; 189(6):2031-8. PubMed ID: 23313195
[TBL] [Abstract][Full Text] [Related]
37. Postcoital vomiting after taking sildenafil?
Lamb M; Brahm N; Fox MD
J Fam Pract; 2013 Feb; 62(2):61-2. PubMed ID: 23405374
[No Abstract] [Full Text] [Related]
38. Avanafil for the treatment of erectile dysfunction.
Segal R; Burnett AL
Drugs Today (Barc); 2012 Jan; 48(1):7-15. PubMed ID: 22384456
[TBL] [Abstract][Full Text] [Related]
39. [Cardiovascular complications of phosphodiesterase-5 inhibitors].
Dworzański W; Jaskólska A; Szumiło M; Switalska A; Burdan F
Pol Merkur Lekarski; 2011 Feb; 30(176):139-42. PubMed ID: 21544985
[TBL] [Abstract][Full Text] [Related]
40. [Orally dissolving tablet levitra--a new step in the treatment of patients with erectile dysfunction].
Rasner PI; Pushkar' DIu
Urologiia; 2013; (4):93-6, 98. PubMed ID: 24159775
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
